Vitae/Kevin Dye/Publications: Difference between revisions

From Future Worlds Center Wiki
Jump to navigationJump to search
Line 3: Line 3:
<ol type="1" start="1">
<ol type="1" start="1">


<li> 4-D COMMON OPERATIONAL PICTURE (COP) FOR MISSION ASSURANCE (4D COP) Task Order 0001: Air Force Research Laboratory (AFRL) Autonomy Collaboration in Intelligence, Surveillance, and Reconnaissance (ISR), Electronic Warfare (EW)/Cyber and Combat Identification (CID)
<li> 4-D COMMON OPERATIONAL PICTURE (COP) FOR MISSION ASSURANCE (4D COP) Task Order 0001: Air Force Research Laboratory (AFRL) Autonomy Collaboration in Intelligence, Surveillance, and Reconnaissance (ISR), Electronic Warfare (EW)/Cyber and Combat Identification (CID). Jones, P. H., & Dye, K. M. (2016). 4-D COMMON OPERATIONAL PICTURE (COP) FOR MISSION ASSURANCE (4D COP) Task Order 0001: Air Force Research Laboratory (AFRL) Autonomy Collaboration in Intelligence, Surveillance, and Reconnaissance (ISR), Electronic Warfare (EW)/Cyber and Combat Identification (CID). Dialogic Design International Dayton United States.
<li>
Jones, P. H., & Dye, K. M. (2016). 4-D COMMON OPERATIONAL PICTURE (COP) FOR MISSION ASSURANCE (4D COP) Task Order 0001: Air Force Research Laboratory (AFRL) Autonomy Collaboration in Intelligence, Surveillance, and Reconnaissance (ISR), Electronic Warfare (EW)/Cyber and Combat Identification (CID). Dialogic Design International Dayton United States.\


<li> Bacteriostatic polymer film immobilization. Journal of Biomedical Materials Research Part A, 79(4), 874-881.  El‐Hayek, R. F., Dye, K., & Warner, J. C. (2006).


<li> El‐Hayek, R. F., Dye, K., & Warner, J. C. (2006). Bacteriostatic polymer film immobilization. Journal of Biomedical Materials Research Part A, 79(4), 874-881.
<li> Developing Collaborative Leadership to Reframe the Safe Use of Pharmaceuticals as a National Health Priority. Final Report, CWA Ltd. Dye, K. M., Feudtner, C., Post, D., & Vogt, E. M. (1999).  


 
<li> Developing a Consensus on the Accountability and Responsibility for the Safe Use of Pharmaceuticals. Washington, DC: The National Patient Safety Foundation. Dye, K. M., Post, D., & Vogt, E. (1999).  
<li> Dye, K. M., Feudtner, C., Post, D., & Vogt, E. M. (1999). Developing Collaborative Leadership to Reframe the Safe Use of Pharmaceuticals as a National Health Priority. Final Report, CWA Ltd.
 
 
<li> Dye, K. M., Post, D., & Vogt, E. (1999). Developing a Consensus on the Accountability and Responsibility for the Safe Use of Pharmaceuticals. Washington, DC: The National Patient Safety Foundation.


<li> Environmental Impact Assessment Review. Krieg EJ, Faber DR, Steinemann A, Daughton CG, Montague P, Bailey D, Solomon G, Warner JC, Cannon AS, Dye KM, Tickner JA.  
<li> Environmental Impact Assessment Review. Krieg EJ, Faber DR, Steinemann A, Daughton CG, Montague P, Bailey D, Solomon G, Warner JC, Cannon AS, Dye KM, Tickner JA.  
Ninja, Ninla, Bots, Bureaucrats, recentchangescleanup, Administrators
4,970

edits

Navigation menu